Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV - Wikidata - wikimedia - TriplyDB

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

http://www.wikidata.org/entity/Q37252421

about

Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts Treatment optimization for HIV/HCV co-infected patients.Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic.Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort.Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients Hepatitis C virus infection in the human immunodeficiency virus infected patient.Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.HCV and HIV co-infection: mechanisms and management.Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons.Update on Hepatitis C Virus and HIV Coinfection.Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response.Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage.Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection Current management of hepatitis C virus infection in patients with HIV co-infection CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?Cancer prevention in HIV-infected populations.Management of hepatitis C virus infection: the basics The role of viral co-infection in HIV-associated non-AIDS-related cancers Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections.Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.Human immunodeficiency virus and liver disease forum 2012.The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.

P2860

Q26798469-E3DD694C-A6FE-47D9-9E1B-0F0962BD2F23 Q28070280-D1A25810-1647-48B4-AD35-9C7FA1DEAAC4 Q28485972-7DDE694C-7A5D-4487-A55C-041C638E6225 Q30235034-89AC7EEF-4D88-4B76-B1EB-68B4D6E599B8 Q33422417-6F1CB895-9CFB-461C-BC5E-2BD1FB7C90CC Q33576161-12A9E648-1858-4B52-9C55-53766F7EBCE4 Q33589224-C89E9AC2-F3A3-42CA-AE7B-25C2FA42E6B2 Q33647154-D35909BC-2A90-4158-8678-E892EE454D48 Q33712066-4862E83D-BE98-496D-A338-00AC68787AD4 Q33946635-5E5AA57E-85FC-40B3-900B-4DFBD9D0071F Q34168504-586A5337-0844-44ED-8239-DA44E0232FFA Q34626591-501C95E1-91C7-4C76-A8F7-07384C858D3B Q34702334-9B74878D-9300-4143-93F3-4990E9231DEE Q35090634-B4EE2734-0C84-4DF0-A5AB-A67A0A143F92 Q35111937-505552FD-8A9C-4967-8B70-FBA692A1E7D0 Q35150425-FEBDA1BD-C542-498A-B1CC-BE230396AC83 Q35154639-E35F83FA-0882-4508-8FC3-F673AA264236 Q35628281-FE8F86D9-653F-44FE-8970-44C6AC007023 Q35757603-41548CD9-B899-418A-83D4-81F36E2955AB Q35906047-0A3AFDC8-33C3-4EAC-B767-F0DF8F208F34 Q35933802-27625A09-B1C7-4B18-BAF2-02B4302463B2 Q35952818-9977629E-767E-47F5-8EBE-7736F6C18BFF Q36158135-8E14FEB8-F15D-469B-80C5-15C44EDF8E75 Q36330435-A0A30EFF-4860-49CB-8A4D-A2E822F0BAEE Q36365938-7FC4B2C5-A245-47C0-9B58-30AA4C14C362 Q36505470-2BDE1E94-0800-437F-B2D2-EF9DC5C0250C Q36590774-6DA4352E-E008-4F5A-8C18-900CA4A82DC5 Q36619647-8A9A72C4-E133-4536-A356-AC8939CDB901 Q36650557-ECFF37A7-EA37-45D1-ACDC-855DE12E0DCD Q36676374-9A940119-84DC-4783-AD24-3DD3574CD52D Q36680086-7D598444-344B-4FE6-8337-82DE145B92B7 Q36949500-67DED176-E002-4B34-B014-314890DAC081 Q36960884-BFD701AD-E8B7-4231-A3BD-54F2F5B05C98 Q36967076-A72B77F9-D7D9-4BAE-99F3-C0BA4DD7C34C Q37014193-8F8C1D3B-A77C-447E-8826-4A25227DABBE Q37100669-8C2D7B7C-EC2F-4CF1-8379-7648DEE7177A Q37146827-C669166B-1E2C-41C2-83F5-95C518CC6DE0 Q37202576-A5F59D72-FB0D-4FC6-B287-E9447B385AFD Q37361082-47203326-1C18-4C38-AB80-D3CB576ECE54 Q37455611-A3135F22-4F2E-4925-8179-DC00D203D103

P2860

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

http://www.wikidata.org/entity/Q37252421

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Relationship of liver disease ...... adults coinfected with HIV/HCV

@en

Relationship of liver disease ...... dults coinfected with HIV/HCV.

@nl

type

label

Relationship of liver disease ...... adults coinfected with HIV/HCV

@en

Relationship of liver disease ...... dults coinfected with HIV/HCV.

@nl

prefLabel

Relationship of liver disease ...... adults coinfected with HIV/HCV

@en

Relationship of liver disease ...... dults coinfected with HIV/HCV.

@nl

P1433

Q37252421-F600CB9F-990A-4FE1-A9BD-A2079CB3931E

P1476

Q37252421-FA67EF5F-FC1F-4A4A-A9EF-8F3A632E1263

P2093

Q37252421-0EA190ED-2ED3-41A4-B608-E5458F9B0122

Q37252421-32527C59-790B-4E94-AF93-C66F8E35445A

Q37252421-368C2689-7BAF-49D2-BEB4-40DAA89A4A56

Q37252421-466D2C88-6BB7-42DB-A919-20D2F86F3783

Q37252421-8122DAAB-A774-49E9-AEB3-44D1D06E8F38

Q37252421-A9648EE9-6DAC-4234-9FA3-052F0E0BC27B

Q37252421-BC2B886C-84BC-417B-BE1A-72AA84E5CEF5

Q37252421-CA9ECDC9-2EC8-4C90-9012-E2EDA536D7AC

Q37252421-EC3AA8C3-AC5B-415F-8E39-C601D98C2966

P2860

Q37252421-0B7EE318-184C-439D-952E-9D204272FF9B

Q37252421-1EB54CCD-6D17-47DD-BC0F-C511D89F59BA

Q37252421-222B3411-6774-4A06-8F3C-D9BA4490ED4B

Q37252421-29139EB4-B912-4B78-8F60-3FF6B76C8611

Q37252421-2B9A0A70-93DA-40F4-9841-A5FC66FB2E30

Q37252421-31B865AC-2833-42EE-9DA5-83F2305094F9

Q37252421-3E9EF4CE-3A96-4E60-BD04-725A056FCF0F

Q37252421-45C6B683-5E40-4D89-BFF7-672DD4813C13

Q37252421-5051CBB7-B674-481D-87BC-01BBC652E6F6

Q37252421-56EF1073-4FFD-4962-A46E-A340C7B2FB80

P304

Q37252421-B1EE09FC-0343-44A9-B34D-B7E82AB497EF

P31

Q37252421-E96B09AD-CD70-475A-B511-A0ED0086451F

P356

Q37252421-9C1247C2-E339-4993-8E67-E5CA806CE8EC

P407

Q37252421-E4E90C21-830C-48EB-8D67-FEF44CC61745

P433

Q37252421-B38B929B-D720-4EFF-ABDC-864610D71E1A

P478

Q37252421-12549325-F7E6-4A31-A432-177E28BEAA54

P577

Q37252421-3B376FB2-240F-4385-91C5-91E04347FE1A

P5875

Q37252421-42BBB148-B11E-4380-847E-B96F653DAAB5

P698

Q37252421-D8A36BCB-06CB-40BF-A1A0-C341B2B515E0

P921

Q37252421-0958DADB-092E-47DD-B2C8-D58E03743854

P932

Q37252421-75BBEFE1-B5EA-475B-BDAD-4E5CDB9FE4E7

P356

P1433

Journal of the American Medical Association

P1476

Relationship of liver disease ...... adults coinfected with HIV/HCV

@en

P2093

Berkeley N Limketkai

http://www.w3.org/2001/XMLSchema#string

Catherine G Sutcliffe

http://www.w3.org/2001/XMLSchema#string

David L Thomas

http://www.w3.org/2001/XMLSchema#string

Mark S Sulkowski

http://www.w3.org/2001/XMLSchema#string

Michael S Torbenson

http://www.w3.org/2001/XMLSchema#string

Richard D Moore

http://www.w3.org/2001/XMLSchema#string

Sherilyn C Brinkley

http://www.w3.org/2001/XMLSchema#string

Shruti H Mehta

http://www.w3.org/2001/XMLSchema#string

Yvonne M Higgins

http://www.w3.org/2001/XMLSchema#string

P2860

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Diagnosis, management, and treatment of hepatitis C: an update

Telaprevir for previously untreated chronic hepatitis C virus infection

Boceprevir for untreated chronic HCV genotype 1 infection

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

Prognostic factors associated with hepatitis C disease: a case-control study utilizing U.S. multiple-cause-of-death data

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

P304

370-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2012.7844

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

308

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229436801

http://www.w3.org/2001/XMLSchema#string

P698

22820790

http://www.w3.org/2001/XMLSchema#string

P921

P932

3807214

http://www.w3.org/2001/XMLSchema#string